Toddlers Age 1-2 With CF Can Now Be Treated With Kalydeco in Canada
Jan 29, 2019 07:00 am | Alice Melão
Health Canada has approved the use of Kalydeco (ivacaftor) in toddlers age 1-2 years with certain genetic mutations that prevent the correct functioning of the CFTR protein, the therapy’s developer announced. With a pill taken twice a day, Kalydeco, by Vertex Pharmaceuticals, makes it possible to resolve the underlying cause of cystic fibrosis (CF) in people with […]
The post Toddlers Age 1-2 With CF Can Now Be Treated With Kalydeco in Canada appeared first on Cystic Fibrosis News Today. |
Patients with cystic fibrosis (CF) who have never been exposed to the Pseudomonas aeruginosa bacterium have a milder form of the disease, a retrospective study based on registry data suggests. The study, “Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry,” was published in the journal Plos One. […]
A running joke among my friends is that “Brad hates kids.” Maybe I did. I could blame that on my obsession with having adult friends as a teen — in comparison to them, children seemed so naive. So yeah, people would always find me rolling my eyes at kids or saying their jokes are stupid. The […]
Health Canada has approved the use of Kalydeco (ivacaftor) in toddlers age 1-2 years with certain genetic mutations that prevent the correct functioning of the CFTR protein, the therapy’s developer announced. With a pill taken twice a day, Kalydeco, by Vertex Pharmaceuticals, makes it possible to resolve the underlying cause of cystic fibrosis (CF) in people with […]
